{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:38:44Z","timestamp":1759451924328,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.11.050","type":"journal-article","created":{"date-parts":[[2011,11,21]],"date-time":"2011-11-21T01:23:14Z","timestamp":1321838594000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine"],"prefix":"10.1016","volume":"30","author":[{"given":"Heike","family":"Claus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus S.","family":"J\u00f6rdens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavla","family":"Kriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Musilek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Jarva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christin","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.vaccine.2011.11.050_bib0005","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.050_bib0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1574-6976.2006.00052.x","article-title":"Lessons from meningococcal carriage studies","volume":"31","author":"Caugant","year":"2007","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.050_bib0015","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1128\/JCM.42.11.5146-5153.2004","article-title":"Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway","volume":"42","author":"Yazdankhah","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.11.050_bib0020","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/428590","article-title":"Genetic analysis of meningococci carried by children and young adults","volume":"191","author":"Claus","year":"2005","journal-title":"J Infect Dis"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2011.11.050_bib0025","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1099\/00221287-148-6-1813","article-title":"Many carried meningococci lack the genes required for capsule synthesis and transport","volume":"148","author":"Claus","year":"2002","journal-title":"Microbiology"},{"issue":"7","key":"10.1016\/j.vaccine.2011.11.050_bib0030","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1128\/JCM.42.7.2898-2901.2004","article-title":"Bacteremia in an immunocompromised patient caused by a commensal Neisseria meningitidis strain harboring the capsule null locus (cnl)","volume":"42","author":"Vogel","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.11.050_bib0035","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/512084","article-title":"Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso","volume":"195","author":"Findlow","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.11.050_bib0040","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/427875","article-title":"Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus","volume":"40","author":"Hoang","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.050_bib0045","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3201\/eid1211.060682","article-title":"Spatiotemporal analysis of invasive meningococcal disease, Germany","volume":"12","author":"Elias","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.11.050_bib0050","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.11.050_bib0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1017\/S0950268805005339","article-title":"The natural history of meningococcal carriage and disease","volume":"134","author":"Trotter","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2011.11.050_bib0060","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","article-title":"Neisseria lactamica protects against experimental meningococcal infection","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect Immun"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2011.11.050_bib0065","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/j.vaccine.2009.01.092","article-title":"On the relationship between meningococcal transmission dynamics and disease: remarks on humoral immunity","volume":"27","author":"Guzzetta","year":"2009","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2011.11.050_bib0070","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMra0906357","article-title":"Advances in the development of vaccines against Neisseria meningitidis","volume":"362","author":"Tan","year":"2010","journal-title":"N Engl J Med"},{"issue":"29","key":"10.1016\/j.vaccine.2011.11.050_bib0075","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.vaccine.2011.11.050_bib0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.050_bib0085","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1084\/jem.20020407","article-title":"NadA, a novel vaccine candidate of Neisseria meningitidis","volume":"195","author":"Comanducci","year":"2002","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2011.11.050_bib0090","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0915162107","article-title":"Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans","volume":"107","author":"Serruto","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2011.11.050_bib0095","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","article-title":"MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain","volume":"23","author":"Oster","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2011.11.050_bib0100","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2011.11.050_bib0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","article-title":"The VR2 epitope on the PorA P1. 7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB","volume":"13","author":"Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"21","key":"10.1016\/j.vaccine.2011.11.050_bib0110","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","article-title":"Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus","volume":"27","author":"Bambini","year":"2009","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2011.11.050_bib0115","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.vaccine.2011.11.050_bib0120","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.050_bib0125","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0b013e3181f59f6d","article-title":"Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2011.11.050_bib0130","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.vaccine.2011.11.050_bib0135","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1462-5822.2005.00559.x","article-title":"Carbohydrate composition of meningococcal lipopolysaccharide modulates the interaction of Neisseria meningitidis with human dendritic cells","volume":"7","author":"Kurzai","year":"2005","journal-title":"Cell Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.11.050_bib0140","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/JCM.36.9.2465-2470.1998","article-title":"Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts","volume":"36","author":"Vogel","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2011.11.050_bib0145","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/mic.0.26131-0","article-title":"Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component","volume":"149","author":"Thompson","year":"2003","journal-title":"Microbiology"},{"issue":"10","key":"10.1016\/j.vaccine.2011.11.050_bib0150","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1128\/IAI.72.10.5955-5962.2004","article-title":"Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design","volume":"72","author":"Urwin","year":"2004","journal-title":"Infect Immun"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2011.11.050_bib0155","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1099\/mic.0.027995-0","article-title":"Variation of the factor H-binding protein of Neisseria meningitidis","volume":"155","author":"Brehony","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2011.11.050_bib0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"Scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinform"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.050_bib0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/bioinformatics\/14.1.68","article-title":"SplitsTree: analyzing and visualizing evolutionary data","volume":"14","author":"Huson","year":"1998","journal-title":"Bioinformatics"},{"issue":"Suppl. 8","key":"10.1016\/j.vaccine.2011.11.050_bib0170","doi-asserted-by":"crossref","first-page":"I46","DOI":"10.1016\/j.vaccine.2008.11.068","article-title":"Factor H-binding protein, a unique meningococcal vaccine antigen","volume":"26","author":"Pizza","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.11.050_bib0175","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"37","key":"10.1016\/j.vaccine.2011.11.050_bib0180","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2011.11.050_bib0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s004300050018","article-title":"Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat","volume":"185","author":"Vogel","year":"1996","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.11.050_bib0190","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","journal-title":"J Med Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.11.050_bib0195","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20072577","article-title":"A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies","volume":"205","author":"Uria","year":"2008","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.11.050_bib0200","doi-asserted-by":"crossref","first-page":"e9413","DOI":"10.1371\/journal.pone.0009413","article-title":"The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease","volume":"5","author":"Kugelberg","year":"2010","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2011.11.050_bib0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.050_bib0210","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/JCM.00936-09","article-title":"Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales","volume":"47","author":"Lucidarme","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.11.050_bib0215","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.0800151105","article-title":"Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis","volume":"105","author":"Schoen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.050_bib0220","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.050_bib0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JCM.01322-06","article-title":"IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone","volume":"45","author":"Elias","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.11.050_bib0230","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/424464","article-title":"Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease","volume":"190","author":"Litt","year":"2004","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2011.11.050_bib0235","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1073\/pnas.87.10.3982","article-title":"Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid\/polyanion binding site on factor H","volume":"87","author":"Meri","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5459","key":"10.1016\/j.vaccine.2011.11.050_bib0240","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.vaccine.2011.11.050_bib0245","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.vaccine.2010.05.014","article-title":"Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus","volume":"28","author":"Giuliani","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.050_bib0250","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.050_bib0255","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2010.11.064","article-title":"Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1","volume":"29","author":"Brunelli","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.11.050_bib0260","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1086\/374740","article-title":"Genetic basis for nongroupable Neisseria meningitidis","volume":"187","author":"Dolan-Livengood","year":"2003","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:20:09Z","timestamp":1759400409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11018354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11018354"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}